Abstract
Pain and variable uptake remain practical barriers to needle-based delivery. Device-level vibration has emerged as a simple strategy for improving tolerability and dispersion, but its fluid-mechanical basis remains incomplete. Using a lattice Boltzmann model with a porous-media skin surrogate, we applied time-periodic inlet pressures at 0%, 16.6% (ΔP₁), and 35.1% (ΔP₂) amplitudes to Newtonian, model shear-thinning, and clinically measured protein formulations. We quantified the wall shear stress, wetted area, dispersion length, and pressure cost over one cycle. Vibration increased the normalized wetted area by 10.6% for Newtonian flow and by 15.9% and 21.3% for the non-Newtonian cases at ΔP₁ and ΔP₂, respectively, while advancing the penetration front and lateral dispersion. The one-cycle pressure cost per wetted area decreased by 3.9% for Newtonian flow and by 5.96% and 7.80% for non-Newtonian flows. For shear-thinning fluids, the wall-shear history was reshaped, with a brief early amplification and late-phase mean reductions of 10.3% and 13.3% at ΔP₁ and ΔP₂. These results establish a fluid-mechanical mechanism linking clinically relevant vibration amplitudes to reduced sustained shear exposure, deeper and broader depot formation, and improved conditions for drug uptake.